B+
Bull case
25%
Probability
Target price
$195.00
Analysis reference price unavailable
Analysis 2026-09-08 · RankAlpha Sentiment Codex
A
AgilentANYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The Q3 beat, strong core growth, improving end markets, operational leverage, product launches, and raised FY2026 outlook support continued earnings momentum [#SEC-8K-2026-08-26].
Posture
Constructive
Lead driver
Sentiment
What changed
8 setup hits (3d) with net bullish as of 2026-09-08.
What can break
Analyst target count, post-earnings estimate revisions, and options positioning are unavailable.
Momentum
73
Value
62
Sentiment
88
Setup hits (3d)
8 · Net Bullish
AI TargetsBase $176.17 · Bull $195.00 · Bear $135.00Analysis 2026-09-08; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-08 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-08
Investment thesis
As of 2026-09-08
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-08. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Bullish
Target $176.17
Why
Momentum73 · Δ7d -6.6
Value62 · Δ7d -0.0
Sentiment88 · Δ7d +13.7
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Confirming evidence
- • 8 setup hits (3d) with net bullish as of 2026-09-08.
- • Sentiment remains the lead driver in the composite, 7D delta +13.7.
Contradictions & invalidation
- • Analyst target count, post-earnings estimate revisions, and options positioning are unavailable.
- • Biocare closing and integration timing remain execution variables [#PR-2026-03-09].
- • The raised outlook still requires sustained demand and execution, while the Q3 result benefited from tariff refunds and the Biocare catalyst remains subject to closing and integration risk.
Catalyst clock
2026-08-26
Q3 FY2026 beat and raised outlook
Lead driver: Sentiment · See AI snapshot
Momentum
73
9% active weight
Current posture
7d trendSoftening
Δ7d
-6.6
Δ21d
-4.4
Value
62
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
88
62% active weight
Current posture
7d trendImproving
Δ7d
+13.7
Δ21d
+49.3
Why this grade
Composite grade A. Momentum 72.8 / Value 61.5 / Sentiment 88.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-08. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$176.17
Analysis reference price unavailable
Analysis 2026-09-08 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$135.00
Analysis reference price unavailable
Analysis 2026-09-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$41.93B
Beta
1.30
Shares Out
282.43M
P/E (TTM)
31.3
P/S (TTM)
5.83
P/FCF (TTM)
46.58
Rev YoY
+10.0%
EPS YoY
+58.8%
Gross Margin
+52.8%
Op Margin
+22.9%
Net Debt
$1.75B
Current Ratio
2.10
As of 2026-09-08 • Updated nightlySource: Internal modelMethods & Data